AP NEWS

Global Anticancer Drugs Market by Drug Type, Cancer Type, Therapy and Region - Forecast to 2023: An $139.4 Billion Opportunity - ResearchAndMarkets.com

October 1, 2018

DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Global Anticancer Drugs Market - by Drug Type, Cancer Type, Therapy, Region - Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2017-2023)” report has been added to ResearchAndMarkets.com’s offering.

The global anticancer drugs market was 94.5 billion USD in 2017 and will reach 139.4 billion USD by 2023 with a CAGR of 6.69% during the period.

The growing awareness towards cancer diagnosis and treatment, and increasing research and development activities drive the growth of the market. However, high cost of treatment may hinder the growth of the market.

The U.S., U.K. and Germany are leading the market due to developed healthcare infrastructure and government initiatives to increase public awareness. Asia-Pacific will show significant growth rate owing to increase in cancer incidences and growing population in certain economies like India, China, Japan and South Korea.

Industry Trends & Updates

Eli Lilly acquired California-based ARMO BioScience and Montreal-based AurKa Pharma Inc. Israeli scientists invented system to deliver cancer drugs to children using nanotechnology.

Companies Profiled

Celgene Pfizer Novartis Eli Lilly Bayer Takeda Amgen GlaxoSmithKline Bristol-Myers Roche Holding Johnson & Johnson Gilead Otsuka Teva ARIAD

Key Topics Covered

1. Research Methodology

2. Executive Summary

3. Market Overview

4. Market Dynamics

5. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Drug Type

6. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Cancer Type

7. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Therapy

8. Global Anticancer Drugs Market Segmentation, Forecasts and Trends - by Region

9. Company Market Share Analysis

10. Company Profiles

11. Industry Structure

12. Global Anticancer Drugs Market - The Road Ahead

For more information about this report visit https://www.researchandmarkets.com/research/mdxzww/global_anticancer?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005762/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Oncology Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/01/2018 12:06 PM/DISC: 10/01/2018 12:06 PM

http://www.businesswire.com/news/home/20181001005762/en

AP RADIO
Update hourly